SBIR Phase I: A Wearable for Remote Monitoring of the COVID-19 Patient Population

  • Funded by National Science Foundation (NSF)
  • Total publications:0 publications

Grant number: 2031714

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2020
    2021
  • Known Financial Commitments (USD)

    $256,000
  • Funder

    National Science Foundation (NSF)
  • Principal Investigator

    Alireza Akhbardeh
  • Research Location

    United States of America
  • Lead Research Institution

    CEREVU MEDICAL INC
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    Digital HealthInnovation

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop real-time monitoring of COVID-19 symptoms toward public health objectives. This project will provide healthcare systems the ability to remotely manage patients during quarantine, protecting hospitals and healthcare workers from unnecessary visits that can quickly overwhelm the healthcare system. This remote monitoring will allow for early identification of patients requiring hospitalization by continuously monitoring key symptoms and notifying patients, caregivers, and loved ones when urgent care is required.

This Small Business Innovation Research (SBIR) Phase I project is to integrate a forehead patch, smartphone/tablet app, firmware, and cloud-based data portal to continuously assess and monitor COVID-19 patients. The first step will be to develop firmware to measure and display key COVID-19 symptoms, such as changes in SpO2/hypoxia, heart rate, respiration rate, and body temperature. The system will also monitor vital signs including dyspnea, myalgia, coughing frequency, and coughing intensity. The monitor user interface will capture non-measurable patient inputs, such as consumption of fluids and food, gastric problems, changes in smell and taste capabilities, and medication usage. Rule-based alert algorithms will be developed to provide notifications to healthcare professionals when critical condition thresholds have been triggered. A datahub and physician dashboard will be developed to remotely monitor large groups of COVID-19 patients.

This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.